Solid Δ

The invention relates to a solid Δ 9 -THC composition containing Δ 9 -THC and a powder former and having a molar ratio of Δ 9 -THC to powder former to form a flowable Δ 9 -THC powder. The powder former is selected from the group consisting of adenine, aspartame, caffeine, lactose, mannitol, nicotinamide, β-nicotinamide adenine dinucleotide, pipecolic acid, saccharin, aspartic acid, glutamic acid, glutamine, histidine, leucine, methionine, phenylalanine, proline, serine, tryptophan, valine, Epigallocatechin Gallate (EGCG), 2-Hydroxypropyl-beta-cyclodextrin (HPbCD), and Trimethyl-beta-cyclodextrin (TOMBC) and mixtures thereof. The invention also relates to methods of making a solid Δ 9 -THC composition of the invention. The Δ 9 -THC may be synthetic Δ 9 -THC or may be extracted Δ 9 -THC. The invention provides pharmaceutical or nutraceutical composition containing a solid Δ 9 -THC composition of the invention and a pharmaceutically- or nutraceutically-acceptable carrier where Δ 9 -THC is present in a pharmaceutically or nutraceutically effective amount. The invention also provides methods of treating a disease, disorder, or condition by administering to a patient in need thereof a therapeutically effective amount of a solid Δ 9 -THC composition. A solid Δ 9 -THC composition of the invention may also be incorporated into food and beverage products.